Oragenics Inc — Liquidità (NYSE:OGEN) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -16.95 M-13.47 M-15.23 M-7.29 M-8.6 M-9.25 M -9.25 M Flussi di cassa derivanti dalle attività di investimento 0-43.88 K-115.52 K-936.28 K0— — Liquidità derivante dalle attività di finanziamento 16.32 M23.14 M-494.92 K283.88 K5.98 M16.78 M 16.78 M Liquidità libera -16.95 M-13.51 M-15.36 M-7.29 M-8.6 M-9.25 M -9.25 M

Notizie

Oragenics modifica l’accordo di vendita at-the-market con Dawson James Securities

Oragenics amends at-the-market sales agreement with Dawson James Securities

Why High Roller Technologies Shares Are Trading Higher By 30%; Here Are 20 Stocks Moving Premarket - American Rebel Holdings (NASDAQ:AREB), Aura Biosciences (NASDAQ:AURA)

Oragenics collabora con Receptor.AI per espandere la pipeline di terapie cerebrali

Oragenics partners with Receptor.AI to expand brain therapeutics pipeline

Oragenics appoints Natasha Giordano to board of directors

Oragenics advances toward phase IIa trials for concussion treatment

Oragenics partners with Sterling for concussion drug production

Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories! - TipRanks.com

Oragenics stock tumbles after announcing $20 million preferred stock offering

Oragenics announces $20 million preferred stock offering

Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium